Roivant Sciences ROIV
NASDAQ ROIV
$36.57 +0.07 (+0.19%)
At close: Sep 30, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Total Non-Current Liabilities (2021 - 2026)

Updated

Roivant Sciences' Total Non-Current Liabilities came in at $378.37 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 74.8% from $216.47 million a year earlier.

Analysis

Roivant Sciences (ROIV) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Total Non-Current Liabilities was $11.88 million, down 35.5% from FY2025.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -53.4% (FY2021 to FY2026).
  • Going back by fiscal year, Total Non-Current Liabilities was $18.42 million in FY2025 (+20.0%), $15.36 million in FY2024 (-98.0%), $764.99 million in FY2023 (+45.9%) and $524.26 million in FY2022 (-3.3%).
  • The five-year range for quarterly Total Non-Current Liabilities is $11.88 million (fiscal Q4 2026) to $4.03 billion (fiscal Q3 2026).
  • Year-over-year, Total Non-Current Liabilities increased in four of the last eight quarters, with growth averaging 29.1%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q3 2026 (growth of 225.9%), and the weakest in fiscal Q4 2024 (a decline of 98.0%).
  • Business Quant data shows ROIV's Total Non-Current Liabilities at $11.88 million (Q4 2026), $4.03 billion (Q3 2026) and $256.97 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Roivant Sciences 26.38 Bn 27.07 Bn 1.16 Mn 378.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 378.37 Mn
Mar 31, 2026 11.88 Mn
Dec 31, 2025 4.03 Bn
Sep 30, 2025 256.97 Mn
Jun 30, 2025 216.47 Mn
Mar 31, 2025 18.42 Mn
Dec 31, 2024 1.24 Bn
Sep 30, 2024 625.69 Mn
Jun 30, 2024 599.50 Mn
Mar 31, 2024 15.36 Mn
Dec 31, 2023 668.64 Mn
Sep 30, 2023 734.74 Mn
Jun 30, 2023 785.61 Mn
Mar 31, 2023 764.99 Mn
Dec 31, 2022 754.35 Mn
Sep 30, 2022 692.28 Mn
Jun 30, 2022 836.85 Mn
Mar 31, 2022 524.26 Mn
Dec 31, 2021 543.94 Mn
Sep 30, 2021 666.31 Mn
API Access

Roivant Sciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ROIV&period=max&api_key=YOUR_API_KEY